- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03096860
Effect of Concurrent Hookah and Alcohol Consumption on Smoking Topography and Toxicant Exposure
October 11, 2017 updated by: Eleanor Leavens, Oklahoma State University
The purpose of the current study is to investigate in a prospective randomized cross-over trial, the impact of alcohol versus a placebo drink on smoking behavior and topography (duration and frequency of puffing), abuse liability, and toxicity.
It is hypothesized that drinking alcohol before smoking will be associated with longer puffs and shorter duration between puffs and greater abuse liability and toxicity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- The Oklahoma Tobacco Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Report using hookah at least 1 time per month over the past 6 months
- Are at least 21 years old
- Speak and understand English
- Do not currently suffer from lung disease including asthma, CF, or COPD
- Do not currently suffer from heart disease
- Are not currently pregnant or breast-feeding or have plans to become pregnant or begin breast-feeding at any point during the study
- No current, regular use of >5 cigarettes or other tobacco products (e.g., e-cig, cigar, etc.) per month.
- No current marijuana use > 5 times per month
- No use of illicit drugs during the past 30 days
- willing to provide informed consent and abstain from all tobacco, nicotine, and marijuana use for at least 12 hours and abstain from alcohol for at least 24 hours prior to each of the two sessions
- Live within 25 miles of the study location.
- Have a friend who is eligible and willing to participate.
- Consume 2 or more or one or more drinks per episode for men and women, respectively
- Drink alcohol at least one time per week
- Not currently be seeking treatment for alcohol use
Able to answer at least two hookah-specific screening questions from the screener.
-
Exclusion Criteria:
- Hookah use less than one time per month over the past 6 months
- Under the age of 21
- Unwilling to abstain from alcohol for 24 hours and tobacco and nicotine products 12 hours prior to each study visit
- Live more than 25 miles from the study location
- Pregnant or breast feeding or plan to become pregnant or begin breast feeding at any point in the study -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Alcohol consumption and hookah
|
Comparison of alcohol consumption vs. placebo consumption and hookah smoking.
|
|
Placebo Comparator: Placebo consumption and hookah
|
Comparison of alcohol consumption vs. placebo consumption and hookah smoking.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total volume smoke inhaled
Time Frame: up to 2 hours
|
hookah topography
|
up to 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 22, 2017
Primary Completion (Actual)
October 10, 2017
Study Completion (Actual)
October 10, 2017
Study Registration Dates
First Submitted
March 20, 2017
First Submitted That Met QC Criteria
March 24, 2017
First Posted (Actual)
March 30, 2017
Study Record Updates
Last Update Posted (Actual)
October 13, 2017
Last Update Submitted That Met QC Criteria
October 11, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIH/NIDA F31 DA04252
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use, Unspecified
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
University of Rhode IslandCompletedAlcohol Use, UnspecifiedUnited States
-
Zeno Functional Foods, LLCINQUIS Clinical Research Ltd.CompletedAlcohol Use, UnspecifiedCanada
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Enrolling by invitationAlcohol Use, UnspecifiedUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Use, UnspecifiedUnited States
-
Pivot Health Technologies Inc.Withdrawn
-
Virginia Commonwealth UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of Central FloridaCompleted
-
UConn HealthNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of TexasRecruitingAlcohol Use, UnspecifiedUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH); National Center for Complementary and...CompletedTobacco Use | Alcohol Use, UnspecifiedUnited States
Clinical Trials on Active alcohol consumption
-
Fundacion Clinica Valle del LiliHospital Universitario del Valle Evaristo GarciaRecruitingAbdominal Injuries | Substance-related Disorders | Alcohol Intoxication | Penetrating Abdominal TraumaColombia
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; IBRAVINCompletedRed Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) - WineFlora StudyAtherosclerosis | Gut Microbiota | Trimethylamine-N-oxide | Effects of Red Wine
-
Appalachian State UniversityCompleted
-
University of Missouri-ColumbiaCompleted
-
eSwiss Medical & Surgical CenterCompletedCognitive Function | Alcohol Consumption | Bariatric Surgery
-
TNOCompleted
-
TNOCompleted
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Arizona State UniversityCompletedHeavy Drinking | Sexual AggressionUnited States
-
Baris GencerSwiss National Science Foundation; University of BernRecruitingMyocardial InfarctionSwitzerland
-
Carolyn LaucknerNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAcquired Immunodeficiency Syndrome | Alcohol Drinking | HIV/AIDSUnited States